A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Neogenomics Inc stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 30,707 shares of NEO stock, worth $526,625. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,707
Previous 30,707 -0.0%
Holding current value
$526,625
Previous $452,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 30, 2024

BUY
$11.67 - $20.73 $59,096 - $104,976
5,064 Added 19.75%
30,707 $496,000
Q3 2023

Oct 25, 2023

BUY
$12.15 - $17.85 $46,619 - $68,490
3,837 Added 17.6%
25,643 $315,000
Q1 2023

May 08, 2023

BUY
$9.09 - $19.45 $22,697 - $48,566
2,497 Added 12.93%
21,806 $379,000
Q4 2022

Feb 01, 2023

BUY
$6.45 - $12.07 $23,697 - $44,345
3,674 Added 23.5%
19,309 $178,000
Q4 2021

Feb 01, 2022

BUY
$30.49 - $48.49 $130,954 - $208,264
4,295 Added 37.87%
15,635 $533,000
Q1 2021

May 03, 2021

SELL
$41.56 - $59.88 $68,241 - $98,322
-1,642 Reduced 12.65%
11,340 $547,000
Q4 2020

Jan 28, 2021

BUY
$36.08 - $56.47 $32,508 - $50,879
901 Added 7.46%
12,982 $699,000
Q2 2020

Jul 28, 2020

BUY
$24.21 - $31.02 $59,290 - $75,967
2,449 Added 25.43%
12,081 $374,000
Q1 2020

May 06, 2020

BUY
$20.5 - $34.53 $27,347 - $46,063
1,334 Added 16.08%
9,632 $266,000
Q4 2019

Jan 21, 2020

BUY
$18.96 - $29.84 $47,779 - $75,196
2,520 Added 43.61%
8,298 $243,000
Q3 2019

Oct 18, 2019

BUY
$19.12 - $26.24 $14,129 - $19,391
739 Added 14.67%
5,778 $110,000
Q1 2019

Apr 29, 2019

SELL
$12.14 - $20.46 $9,457 - $15,938
-779 Reduced 13.39%
5,039 $103,000
Q4 2017

Jan 31, 2018

BUY
$8.02 - $11.18 $18,349 - $25,579
2,288 Added 64.82%
5,818 $52,000
Q3 2017

Nov 08, 2017

BUY
$9.11 - $11.26 $32,158 - $39,747
3,530
3,530 $39,000

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.16B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.